These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 7646823)

  • 1. Prevention and management of extravasation of cytotoxic drugs.
    Bertelli G
    Drug Saf; 1995 Apr; 12(4):245-55. PubMed ID: 7646823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidotes to vesicant chemotherapy extravasations.
    Dorr RT
    Blood Rev; 1990 Mar; 4(1):41-60. PubMed ID: 2182147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
    Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
    J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extravasation of cytotoxic agents].
    Nogler-Semenitz E; Mader I; Fürst-Weger P; Terkola R; Wassertheurer S; Giovanoli P; Mader RM
    Wien Klin Wochenschr; 2004 May; 116(9-10):289-95. PubMed ID: 15237653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Oncology Nursing Society extravasation guidelines.
    Wengström Y; Margulies A;
    Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extravasation of chemotherapeutic agents: prevention and therapy].
    Jordan K; Grothe W; Schmoll HJ
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):33-7. PubMed ID: 15619172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: topical DMSO for mitomycin-C-induced skin ulceration.
    Alberts DS; Dorr RT
    Oncol Nurs Forum; 1991; 18(4):693-5. PubMed ID: 1906166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extravasation of cytostatic drugs].
    Pikó B; Puskásné Szatmári K; Bassam A; Csiffári M; Dimák S; Szabó Z; Ocsai H; Csotye J
    Magy Onkol; 2011 Mar; 55(1):4-13. PubMed ID: 21617786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of perivascular extravasation of cytostatic agents].
    Rauh J; Pluntke S; Müller Ch
    MMW Fortschr Med; 2004 Aug; 146(31-32):23-4, 26-7. PubMed ID: 15529703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the extravasation of anti-neoplastic agents.
    Boulanger J; Ducharme A; Dufour A; Fortier S; Almanric K; ;
    Support Care Cancer; 2015 May; 23(5):1459-71. PubMed ID: 25711653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents.
    Casiraghi A; Ardovino P; Minghetti P; Botta C; Gattini A; Montanari L
    Arch Dermatol Res; 2007 Jul; 299(4):201-7. PubMed ID: 17370081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapy emergencies.
    Albanell J; Baselga J
    Semin Oncol; 2000 Jun; 27(3):347-61. PubMed ID: 10864222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole.
    Ludwig CU; Stoll HR; Obrist R; Obrecht JP
    Eur J Cancer Clin Oncol; 1987 Mar; 23(3):327-9. PubMed ID: 3595692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Introduction of a clinical protocol for extravasation at the National Institute of Oncology, Budapest, Hungary].
    Bartal A; Mátrai Z; Rosta A; Szûcs A
    Magy Onkol; 2011 Mar; 55(1):14-20. PubMed ID: 21617787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity to topical dimethyl sulfoxide (DMSO) when used as an extravasation antidote.
    Creus N; Mateu J; Massó J; Codina C; Ribas J
    Pharm World Sci; 2002 Oct; 24(5):175-6. PubMed ID: 12426960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach.
    Tsavaris NB; Komitsopoulou P; Karagiaouris P; Loukatou P; Tzannou I; Mylonakis N; Kosmidis P
    Cancer Chemother Pharmacol; 1992; 30(4):330-3. PubMed ID: 1643703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extravasation of systemic hemato-oncological therapies.
    Ener RA; Meglathery SB; Styler M
    Ann Oncol; 2004 Jun; 15(6):858-62. PubMed ID: 15151940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous ulceration due to contrast extravasation. Experimental assessment of injury and potential antidotes.
    Elam EA; Dorr RT; Lagel KE; Pond GD
    Invest Radiol; 1991 Jan; 26(1):13-6. PubMed ID: 2022447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
    Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.